Literature DB >> 7923212

Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung.

S Sato1, Y Nakamura, E Tsuchiya.   

Abstract

We compared the frequency of loss of heterozygosity on all autosomal chromosomes among 41 squamous cell carcinomas and 119 adenocarcinomas, to analyze possible relationships of specific tumor suppressor gene(s) to each histological type. On the majority (28 of 36) of chromosomal arms tested, loss of heterozygosity was observed more frequently in squamous cell carcinomas than in adenocarcinomas; in nine of these locations (3p, 3q, 4q, 7p, 9q, 13q, 16q, 17p, and 21q), the frequency was statistically significant (3p, 3q, 4q, 9q, 13q, and 17p, P < 0.01; 7p, 16q, and 21q, P < 0.05, chi 2 test). In squamous cell carcinomas, the frequency of allelic loss on chromosome 9q (67%) fell between the frequencies of loss on chromosomes 3p (82%) or 17p (88%) and chromosome 13q (60%). On the other hand, in adenocarcinomas frequent loss of heterozygosity was observed on chromosomes 8q (32%), 9p (36%), 3p (40%), and 17p (51%). Furthermore, allelic losses on chromosomes 9p, 9q, and 13q tended to correlated with smoking. These results suggest that more genetic changes accumulate during tumorigenesis in squamous cell carcinomas than in adenocarcinomas and that unidentified tumor suppressor genes exist on chromosome 9q for squamous cell carcinoma and on chromosome 8q for adenocarcinoma of the lung. These differences may be related to differences in tumorigenic mechanisms, such as etiological factors, operating in the separate histologies.

Entities:  

Mesh:

Year:  1994        PMID: 7923212

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  34 in total

1.  Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Zhi-Bin Bu; Jie Feng; Ling Peng; Xin-Biao Liao; Xin-Li Zhu; Xiao-Li Sun; Hao-Gang Yu; Dan-Fang Yan; Sen-Xiang Yan
Journal:  Mol Biol Rep       Date:  2013-11-23       Impact factor: 2.316

2.  CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.

Authors:  Yu-Zhong Duan; Liang Zhang; Chang-Chih Liu; Bo Zhu; Wen-Lei Zhuo; Zheng-Tang Chen
Journal:  Mol Biol Rep       Date:  2013-05-08       Impact factor: 2.316

3.  GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis.

Authors:  Chun-hua Xu; Qin Wang; Ping Zhan; Qian Qian; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2014-02-25       Impact factor: 2.316

4.  Association between the CYP2E1 polymorphisms and lung cancer risk: a meta-analysis.

Authors:  Xiang-Hua Ye; Liang Song; Ling Peng; Zhibin Bu; Sen-Xiang Yan; Jie Feng; Xin-Li Zhu; Xin-Biao Liao; Xue-Lin Yu; Danfang Yan
Journal:  Mol Genet Genomics       Date:  2014-10-22       Impact factor: 3.291

5.  Molecular changes in the bronchial epithelium of patients with small cell lung cancer.

Authors:  I I Wistuba; J Berry; C Behrens; A Maitra; N Shivapurkar; S Milchgrub; B Mackay; J D Minna; A F Gazdar
Journal:  Clin Cancer Res       Date:  2000-07       Impact factor: 12.531

6.  Microsatellite alteration at chromosome 3p loci in neuroendocrine and non-neuroendocrine lung tumors. Histogenetic and clinical relevance.

Authors:  K Hurr; B Kemp; S A Silver; A K el-Naggar
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

7.  Familial risk for lung cancer.

Authors:  Madiha Kanwal; Xiao-Ji Ding; Yi Cao
Journal:  Oncol Lett       Date:  2016-12-20       Impact factor: 2.967

8.  Network modeling identifies molecular functions targeted by miR-204 to suppress head and neck tumor metastasis.

Authors:  Younghee Lee; Xinan Yang; Yong Huang; Hanli Fan; Qingbei Zhang; Youngfei Wu; Jianrong Li; Rifat Hasina; Chao Cheng; Mark W Lingen; Mark B Gerstein; Ralph R Weichselbaum; H Rosie Xing; Yves A Lussier
Journal:  PLoS Comput Biol       Date:  2010-04-01       Impact factor: 4.475

9.  P53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies.

Authors:  Shengming Dai; Chen Mao; Lijun Jiang; Guisheng Wang; Hongge Cheng
Journal:  Hum Genet       Date:  2009-04-09       Impact factor: 4.132

10.  Neoplastic transformation of human bronchial cells by lead chromate particles.

Authors:  Hong Xie; Amie L Holmes; Sandra S Wise; Shouping Huang; Cheng Peng; John Pierce Wise
Journal:  Am J Respir Cell Mol Biol       Date:  2007-06-21       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.